Program Description
As new therapies and combinations emerge in the landscape of diffuse large B-cell lymphoma, it is important for pharmacists to remain up to date on emerging data for newer treatment strategies while being familiar with guideline recommendations to individualize treatment. This podcast will build upon recent and emerging data presented at the 2022 American Society of Health-System Pharmacists Midyear Clinical Meeting & Exposition, with a focus on strategies to overcome treatment challenges encountered in clinical practice with the use of novel immunotherapies.
Target audience: Health-system and oncology pharmacists
Type of activity: Knowledge
Release date: December 22, 2022
Expiration date: December 22, 2023
Time to complete activity: 0.5 hour
Fee: Free
Educational Objective
After completing the enduring podcast, participants will be able to:
- Outline various challenges and uncertainties affecting the optimization of treatment with novel immunotherapeutic modalities for relapsed/refractory diffuse large B-cell lymphoma
Victoria Nachar, PharmD, BCOP
Clinical Pharmacist Specialist - Hematology
University of Michigan Rogel Cancer Center
Ann Arbor, Michigan
Laura R. Bobolts, PharmD, BCOP
SVP, Clinical Strategy and Growth
OncoHealth
Plantation, Florida
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hour (0.05 CEU) under the ACPE universal activity number 0290-0000-22-611-H01-P. The activity is available for CE credit through December 22, 2023.
Instructions for Completing the Activity and Receiving CPE Credit
To receive CPE credit, participants must complete the pretest, review the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.
Disclosures
The following contributors have no relevant financial relationships with commercial interests to disclose:
Faculty
Victoria Nachar, PharmD, BCOP
Laura R. Bobolts, PharmD, BCOP
Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Amy H Seung, PharmD, BCOP, FHOPA; Evelina Kolychev, PharmD, BCOP; Abigail Dill; Susan Pordon; Brianna Winters; and Chloe Taccetta.
An anonymous peer reviewer was used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.
Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.
For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms